Simone Claudiani

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Transfusion-Independent iron overload in SF3B1-mutant myelodysplastic syndrome case report.

Transfusion-Independent iron overload in SF3B1-mutant myelodysplastic syndrome case report.

Journal: Leukemia & lymphoma

Published: July 28, 2026

Treatment-free remission in CML patients with prior TKI failure is not influenced by previous BCR::ABL1 kinase domain mutations.

Treatment-free remission in CML patients with prior TKI failure is not influenced by previous BCR::ABL1 kinase domain mutations.

Journal: British journal of haematology

Published: June 01, 2026

Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFR.

Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFR.

Journal: British journal of haematology

Published: May 06, 2026

Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United Kingdom.

Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United Kingdom.

Journal: British journal of haematology

Published: February 25, 2026

Introducing a prognostic score for successful treatment-free remission in chronic myeloid leukaemia.

Introducing a prognostic score for successful treatment-free remission in chronic myeloid leukaemia.

Journal: British journal of haematology

Published: November 21, 2025

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia.

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia.

Journal: EJHaem

Published: June 30, 2025

Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome-insights from a UK center.

Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome-insights from a UK center.

Journal: Research and practice in thrombosis and haemostasis

Published: January 16, 2025

Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score.

Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score.

Journal: Cardio-oncology (London, England)

Published: May 13, 2024

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Journal: Leukemia

Published: April 24, 2024

Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia.

Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia.

Journal: Leukemia & lymphoma

Published: April 23, 2024

Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy.

Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy.

Journal: British journal of haematology

Published: March 27, 2024

Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.

Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.

Journal: American journal of hematology

Published: November 22, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026